Abstract:Background: Some neurodegenerative diseases have an element of neuroinflammation that is triggered by viral nucleic acids, resulting in the generation of type I interferons. In the cGAS-STING pathway, microbial and host-derived DNA bind and activate the DNA sensor cGAS, and the resulting cyclic dinucleotide, 2'3-cGAMP, binds to a critical adaptor protein, stimulator of interferon genes (STING), which leads to activation of downstream pathway components. However, there is limited work demonstrating the activation of the cGAS-STING pathway in human neurodegenerative diseases. Methods: Post-mortem CNS tissue from donors with multiple sclerosis (n = 4), Alzheimer's disease (n = 6), Parkinson's disease (n = 3), amyotrophic lateral sclerosis (n = 3) and non-neurodegenerative controls (n = 11) were screened by immunohistochemistry for STING and relevant protein aggregates (e.g., amyloid-β, α-synuclein, TDP-43). Human brain endothelial cells were cultured and stimulated with the STING agonist palmitic acid (1-400 μM) and assessed for mitochondrial stress (release of mitochondrial DNA into cytosol, increased oxygen consumption), downstream regulator factors, TBK-1/pIRF3 and inflammatory biomarker interferon-β release and changes in ICAM-1 integrin expression. Results: In neurodegenerative brain diseases, elevated STING protein was observed mainly in brain endothelial cells and neurons, compared to non-neurodegenerative control tissues where STING protein staining was weaker. Interestingly, a higher STING presence was associated with toxic protein aggregates (e.g., in neurons). Similarly high STING protein levels were observed within acute demyelinating lesions in multiple sclerosis subjects. To understand non-microbial/metabolic stress activation of the cGAS-STING pathway, brain endothelial cells were treated with palmitic acid. This evoked mitochondrial respiratory stress up to a ~2.5-fold increase in cellular oxygen consumption. Palmitic acid induced a statistically significant increase in cytosolic DNA leakage from endothelial cell mitochondria (Mander's coefficient; p < 0.05) and a significant increase in TBK-1, phosphorylated transcription factor IFN regulatory factor 3, cGAS and cell surface ICAM. In addition, a dose response in the secretion of interferon-β was observed, but it failed to reach statistical significance. Conclusions: The histological evidence shows that the common cGAS-STING pathway appears to be activated in endothelial and neural cells in all four neurodegenerative diseases examined. Together with the in vitro data, this suggests that the STING pathway might be activated via perturbation of mitochondrial stress and DNA leakage, resulting in downstream neuroinflammation; hence, this pathway may be a target for future STING therapeutics.

deficiency triggers autoinflammation via cGAS-STING activation

Lysosomal Control of the Cgas-Sting Signaling.

cGAS-STING-mediated IFN-I Response in Host Defense and Neuroinflammatory Diseases

cGAS- Stimulator of Interferon Genes Signaling in Central Nervous System Disorders

Cellular functions of cGAS-STING signaling

Neuronal STING activation in amyotrophic lateral sclerosis and frontotemporal dementia

RIG-I mediated neuron-specific IFN type 1 signaling in FUS-ALS induces neurodegeneration and offers new biomarker-driven individualized treatment options for (FUS-)ALS

STING-Triggered CNS Inflammation in Human Neurodegenerative Diseases

Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders

cGAS-cGAMP-STING: The three musketeers of cytosolic DNA sensing and signaling.

The cytosolic DNA‐sensing cGAS–STING pathway in neurodegenerative diseases

The triggers of the cGAS-STING pathway and the connection with inflammatory and autoimmune diseases

cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing

The role of STING signaling in central nervous system infection and neuroinflammatory disease

Significance of the cGAS-STING Pathway in Health and Disease

cGAS-STING signalling regulates microglial chemotaxis in genome instability

Role of cGAS-Sting Signaling in Alzheimer's Disease

Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A

Interruption of Post-Golgi STING Trafficking Activates Tonic Interferon Signaling

Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice

The cGAS-STING pathway is an in vivo modifier of genomic instability syndromes